Incyte Corporation has raised its full-year 2026 Opzelura net sales guidance to between $1.05 billion and $1.1 billion following a landmark settlement with the Centers for Medicare & Medicaid Services. The agreement
On July 13, the OCC, FDIC, and NCUA issued interagency guidance addressing how banks should approach lending to individuals not legally authorised to work in the United States. The guidance was issued
More
HSBC Holdings PLC (LSE:HSBA) has agreed to sell its Singapore life and health insurance business to Germany’s Allianz for US$2.1 billion, equivalent to approximately £1.6 billion. The transaction forms part of the
More
The United States has imposed sweeping new tariffs on 60 economies, citing their failure to enforce bans on goods produced using forced labour. The Office of the U.S. Trade Representative acted under
More
BeOne Medicines is investing $300 million into its flagship New Jersey campus to expand domestic drug manufacturing with new small molecule production capabilities. The investment targets the company’s Princeton West Innovation Campus
More
Companies selecting AI models in 2026 face a regulatory minefield that is at least as complex as any technical capability comparison between competing systems. At the G7 summit in June, French President
More
Todd Blanche, nominee for Attorney General, is facing accusations from senior senators that he privately admitted creating a $1.8 billion DOJ fund was a mistake and then denied it in writing. The
More
Global equity markets have long shown a tendency to shrug off geopolitical tensions, pricing in optimism even as conflicts escalate across key regions of the world. That approach is becoming increasingly difficult
More
Aston Martin climbed to the top of the FTSE 250 risers board, giving the struggling luxury carmaker a rare moment of positive momentum in recent sessions. The British automotive brand has faced
More
Outside advisers to the US Food and Drug Administration have recommended relaxing restrictions on a series of popular peptide compounds sought after in wellness circles. The advisory panel delivered its recommendations following
More
The US Court of Appeals for the Tenth Circuit has affirmed in part and reversed in part the dismissal of a false advertising complaint involving two rival pet food companies. The case,
More